NEOCUTIS® Receives O, The Oprah Magazine Fall Beauty 2016 “O-WARD”. MICRO•NIGHT® RICHE Rejuvenating Balm Recognized by O, The Oprah Magazine as Best Night Treatment for Sensitive Skin
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEO CUTIS MICRO•NIGHT® RICHE Rejuvenating Balm is an O, The Oprah Magazine Fall Beauty 2016 “O-Ward” winner for being a top performer in the Night Treatment category for sensitive skin. The publication’s beauty editorial team selected MICRO•NIGHT RICHE Rejuvenating Balm powered by patented MPC™ Technology for helping firm and improve skin’s texture during the night with a blend of micro-proteins and glycerin. The new, customized formulation for dry, aging skin officially launches today, along with MICRO•EYES RICHE Rejuvenating Balm.
“The NEOCUTIS brand is foundational to the Merz Aesthetics portfolio of aesthetic products. The upcoming MICRO•ESSENTIALS RICHE collection has been long awaited by our customers, and it is an honor to have the products’ proof of performance credentialed by O, The Oprah Magazine readers,” said Jim Hartman, Vice President & US Head, Merz Aesthetics and OTC. “This launch showcases how NEO CUTIS continues to launch products that meet specific physician and patient needs.”
Each year the magazine shares the best beauty buys for fall that deserve the coveted “O-Wards” seal, and this year’s winners are featured in the October 2016 issue of O, The Oprah Magazine. NEO CUTIS products are available for purchase exclusively through medical practices and professional skincare providers. For additional information, or to find an authorized NEO CUTIS Skincare provider near you, please visit www.NEO CUTIS.com
About Merz Aesthetics Skincare
Merz Aesthetics Skincare is a division of Merz North America, a specialty healthcare company dedicated to delivering a better total experience in aesthetics and neurosciences. Merz Aesthetics Skincare brings together the precision of Swiss technology and and cutting edge scientific research for advanced breakthroughs in anti-aging and post-procedure skincare. Merz Aesthetics Skincare offers a full line of products designed to help diminish the visible signs of skin aging and address key skincare concerns, available exclusively through medical practices and skincare providers. To learn more about Merz Aesthetics and their Skincare offerings, please visit www.merzusa.com/aesthetics-otc.
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
Merz North America